NL-OMON37687撤回不适用
The role of Factor-VII activating protease in the generation of bradykinin in patients with hereditary angioedema - Factor-VII activating protease in hereditary angioedema/HAE study
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99(—)
入选标准
- •Patients suffering from hereditary angioedema Age >/ 18 yr
排除标准
- 未提供
研究者
相似试验
已完成
不适用
se of recombinant activated Factor Seven in bleeding extracorporeal membrane oxygenation patients post cardiac surgery: a randomised prospective studyExtracorporeal membrane oxygenation (ECMO) patients post cardiac surgeryCirculatory SystemExtracorporeal membrane oxygenation patients (ECMO) post cardiac surgeryISRCTN98382551Department of Health40
已完成
3 期
Recombinant Factor VIIa (NovoSeven) on Restoring Coagulation ActivationHemophilia ANCT00375323Medical University of Vienna
已完成
不适用
The role of tissue factor pathway inhibitor in the development and progression of ischemic cerebral lesions due to cerebral micro-angiopathyLacunar stroke. Stroke.1000796310014523NL-OMON31866Academisch Ziekenhuis Maastricht30
Unknown
3 期
Clinical Study of Recombinant Human Activated Coagulation Factor VII for Injection in Patients With Hemophilia With InhibitorHemophilia AHemophilia BNCT05487976Chia Tai Tianqing Pharmaceutical Group Co., Ltd.50
已完成
3 期
Effect of rFVIIa on Peri-operative Blood Loss in Patients Undergoing Major BurnBurnsNCT00243243United States Army Institute of Surgical Research20
